Can magnesium enhance blood coagulation amongst patients with alcohol induced liver cirrhosis?
- Conditions
- iver transplant candidates with alcohol induced liver cirrhosis and hypomagnesemia (P-Mg under 0,71 or magnesium substitution at least 750 mg/day)MedDRA version: 14.1Level: LLTClassification code 10024667Term: Liver cirrhosisSystem Organ Class: 100000004871Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Registration Number
- EUCTR2012-005454-35-FI
- Lead Sponsor
- Hanna Pitkänen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Age between 18-70 years
Liver transplant candidate
Alcohol induced liver cirrhosis
Hypomagnesemia (P-Mg below 0,71 or magnesium substitution at least 750 mg/vrk)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 15
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 5
Exclusion Criteria
Age under 18 years or over 70 years
Non alcohol induced liver cirrhosis
Normal magnesium plasma levels without magnesium substitution
Magnesium substitution under 750 mg/day
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To find out if by giving magnesium it would be possible to enhance blood coagulation tendencies amongst patients with alcohol induced liver cirrhosis;Secondary Objective: Not applicable;Primary end point(s):
- Secondary Outcome Measures
Name Time Method